Grifols (GIKLY) Gains from Investment Securities (2010 - 2020)

Grifols (GIKLY) posted Gains from Investment Securities of $15.9 million for Q4 2016, up 315.09% quarter-over-quarter from -$7.4 million in Q3 2016, and up 174.85% year-on-year from $5.8 million in Q1 2016.

Grifols (GIKLY) Gains from Investment Securities (2010 - 2020) Analysis & Trends

Grifols (GIKLY) has reported Gains from Investment Securities for 5 consecutive years, with $15.9 million the latest figure, recorded in Q4 2016.

  • Gains from Investment Securities for Q4 2016 came in at $15.9 million, up 174.85% year-over-year; the trailing twelve-month figure through Dec 2016 was -$12.8 million (up 27.13% YoY), and the FY2025 annual result was -$2.3 million, down 117.86% from the prior year.
  • Gains from Investment Securities was $15.9 million for Q4 2016 at Grifols, up from -$7.4 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $473.1 million in Q2 2015 and troughed at -$469.3 million in Q1 2015.
  • Average Gains from Investment Securities over 4 years is -$14.9 million, with a median of -$3.7 million recorded in 2012.
  • Year-over-year, Gains from Investment Securities plunged 4193096.4% in 2013 and surged 174.85% in 2016.
  • Over 4 years, Gains from Investment Securities stood at -$14265.8 in 2012, then plunged by 770741.21% to -$110.0 million in 2013, then soared by 80.65% to -$21.3 million in 2015, then soared by 174.85% to $15.9 million in 2016.
  • Per Business Quant data, the three most recent Gains from Investment Securities figures were $15.9 million in Q4 2016, -$7.4 million in Q3 2016, and -$21.3 million in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Grifols - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 703.98 Mn
Mar 31, 2020 703.98 Mn
Dec 31, 2019 876.80 Mn
Dec 31, 2019 876.80 Mn
Mar 31, 2019 655.51 Mn
Mar 31, 2019 655.51 Mn
Dec 31, 2018 664.30 Mn
Dec 31, 2018 664.30 Mn
Jun 30, 2018 -1.04 Bn
Jun 30, 2018 -1.04 Bn
Mar 31, 2018 1.04 Bn
Mar 31, 2018 1.04 Bn
Dec 31, 2017 959.74 Mn
Dec 31, 2017 959.74 Mn
Jun 30, 2017 -725.94 Mn
Jun 30, 2017 -725.94 Mn
Mar 31, 2017 785.51 Mn
Mar 31, 2017 785.51 Mn
Dec 31, 2016 15.93 Mn
Dec 31, 2016 15.93 Mn